Live Breaking News & Updates on Lungen Clinic

Stay updated with breaking news from Lungen clinic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

EpiEndo Pharmaceuticals: EpiEndo reports Phase 2A results for lead asset, EP395, in COPD

EpiEndo Pharmaceuticals: EpiEndo reports Phase 2A results for lead asset, EP395, in COPD
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United Kingdom , Schleswig Holstein , Henrik Watz , Dennis Riedl , Dave Singh , Maria Bech , Ginny Norris , Pulmonary Research Institute , Epiendo Pharmaceuticals , University Of Manchester , World Economic Forum , Endo Pharmaceuticals , Chronic Obstructive Pulmonary Disease , Principal Investigators , Professor Dave Singh , Respiratory Pharmacology , Medical Director , Medicines Evaluation Unit , Professor Henrik Watz , Lungen Clinic , Chief Medical Officer , Chief Executive Officer , Global Economic Burden , Toyne Sewell Katie Duffell Feaven Abidta ,

EpiEndo reports Phase 2A results for lead asset, EP395, in COPD

REYKJAVIK, Iceland, April 10, 2024 EpiEndo Pharmaceuticals (‘EpiEndo’ or the ‘Company’), a clinical-stage biopharmaceutical company developing a new class of oral, barrier-enhancing, anti-inflammatory therapeutics addressing chronic airway diseases, announces the successful completion of its Phase 2A clinical trial for EP395 in patients diagnosed with Chronic Obstructive Pulmonary Disease (COPD). ....

United Kingdom , Schleswig Holstein , Ginny Norris , Maria Bech , Dave Singh , Henrik Watz , Epiendo Pharmaceuticals , University Of Manchester , World Economic Forum , Pulmonary Research Institute , Chronic Obstructive Pulmonary Disease , Principal Investigators , Professor Dave Singh , Respiratory Pharmacology , Medical Director , Medicines Evaluation Unit , Professor Henrik Watz , Lungen Clinic , Chief Medical Officer , Chief Executive Officer , Global Economic Burden , Endo Pharmaceuticals , Katie Duffell ,

Researchers find dupilumab reduces disease in COPD patients with type 2 inflammation

Researchers find dupilumab reduces disease in COPD patients with type 2 inflammation
newkerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newkerala.com Daily Mail and Mail on Sunday newspapers.

Himachal Pradesh , United States , Surya Bhatt , Klaus Rabe , Devinder Sandhu , University Of Kiel , World Health Organization , New England Journal , Birmingham Department , Medicine Division , Critical Care Medicine , Lungen Clinic ,

Treatment with dupilumab leads to sustained improvements in COPD patients with type 2 inflammation

Chronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements in their disease after treatment with the monoclonal antibody dupilumab, according to a yearlong, Phase 3 clinical trial reported in the New England Journal of Medicine. ....

United States , Lily Ramsey , Surya Bhatt , Klaus Rabe , University Of Kiel , American Thoracic Society , Marnixe Heersink School Of Medicine , International Conference , World Health Organization , New England Journal , Birmingham Department , Medicine Division , Critical Care Medicine , Lungen Clinic ,

Researchers find dupilumab reduces disease in COPD patients with type 2 inflammation

Researchers find dupilumab reduces disease in COPD patients with type 2 inflammation
bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.

United States , Surya Bhatt , Klaus Rabe , University Of Kiel , World Health Organization , New England Journal , Birmingham Department , Medicine Division , Critical Care Medicine , Lungen Clinic ,